Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Exozymes Inc (EXOZ)

Exozymes Inc (EXOZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Exozymes Inc 750 Royal Oaks Drive Suite 106 MONROVIA CA 91016 USA

www.exozymes.com Employees: 31 P: 626-415-1488

Sector:

Medical

Description:

Invizyne Technologies Inc. is a cell-free enzyme-based biomanufacturing technology company. It redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals. Invizyne Technologies Inc. is based in Monrovia, CA.

Key Statistics

Overview:

Market Capitalization, $K 61,826
Enterprise Value, $K 52,106
Shares Outstanding, K 8,400
Float, K 2,318
% Float 27.59%
Short Interest, K 10
Short Float 0.12%
Days to Cover 5.59
Short Volume Ratio 0.24
% of Insider Shareholders 72.41%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -5,860 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,290 K
EBIT, $ -9,000 K
EBITDA, $ -8,790 K

Growth:

1-Year Return -44.44%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.27 on 11/13/25
Next Earnings Date 03/30/26 [--]
Earnings Per Share ttm -0.77
EPS Growth vs. Prev Qtr 3.57%
EPS Growth vs. Prev Year 56.94%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

EXOZ Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -104.58%
Return-on-Assets % -79.55%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 11.41
Book Value/Share 0.64
Interest Coverage -0.44
60-Month Beta 2.53
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar